Citations (69)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (11)
Congfei Pang, Xiaomei Wu, Lauriane Nikuze & Hongying Wei. (2023) Analysis of clinical characteristics and treatment efficacy in two pediatric cases of ANKRD26-related thrombocytopenia. Platelets 34:1.
Read now
Read now
Wenhui Zhang, Shitong Xie, Rongfeng Fu, Yunfei Chen, Wei Liu, Ting Sun, Mankai Ju, Huiyuan Li, Feng Xue, Lei Zhang, Xiaofan Liu & Renchi Yang. (2023) Fatigue and health-related quality of life in patients with immune thrombocytopenia: a longitudinal assessment in China. Expert Review of Hematology 0:0, pages 1-9.
Read now
Read now
Ting Li, Qinqin Liu, Ting Pu, Jing Liu & Aijun Zhang. (2023) Efficacy and safety of thrombopoietin receptor agonists in children and adults with persistent and chronic immune thrombocytopenia: a meta-analysis. Expert Opinion on Pharmacotherapy 24:6, pages 763-774.
Read now
Read now
Alex Bourguignon, Subia Tasneem & Catherine P. Hayward. (2022) Screening and diagnosis of inherited platelet disorders. Critical Reviews in Clinical Laboratory Sciences 59:6, pages 405-444.
Read now
Read now
Xiaofan Liu, Ming Hou, Junmin Li, Jie Jin, Meijuan Huang, Ziqiang Yu, Xiaojun Xu, Xiaohui Zhang & Renchi Yang. (2022) Efficacy and safety of eltrombopag in Chinese patients with chronic immune thrombocytopenia: stage 2 results from a multicenter phase III study. Platelets 33:1, pages 82-88.
Read now
Read now
Yanru Pei, Mingyue Shi, Juanjuan Song, Xiaona Niu, Shengjie Wei, Liurui Dou, Mengyu Xiao, Dan Li, Fangfang Xu, Yanliang Bai & Kai Sun. (2021) Absolute Circulating Leukemic Cells as a Risk Factor for Early Bleeding Events in Patients with Non-High-Risk Acute Promyelocytic Leukemia. Cancer Management and Research 13, pages 4135-4146.
Read now
Read now
Rajeev Sandal, Kundan Mishra, Aditya Jandial, Kamal Kant Sahu & Ahmad Daniyal Siddiqui. (2021) Update on diagnosis and treatment of immune thrombocytopenia. Expert Review of Clinical Pharmacology 14:5, pages 553-568.
Read now
Read now
Qiuni Chen, Yijing Zhang, Yunjie Li, Lijuan Zhang, Wenting Shi, Hong Tao, Kankan Chen, Zhengmei He, Chunling Wang & Liang Yu. (2021) Comparative study between two bleeding grading systems of immune thrombocytopenia purpura. Hematology 26:1, pages 769-774.
Read now
Read now
Tamer A Elbedewy, Mohamed A Elsebaey, Reem A Elkholy, Dina M Tahoon & Samah A Elshweikh. (2020) Intermittent versus Daily Eltrombopag Dosage Protocols for the Treatment of Primary Immune Thrombocytopenia: Real-Life Experience. Journal of Blood Medicine 11, pages 533-542.
Read now
Read now
Yasuyuki Arai, Hiroyuki Matsui, Tomoyasu Jo, Tadakazu Kondo & Akifumi Takaori-Kondo. (2019) Comparison of treatments for persistent/chronic immune thrombocytopenia: a systematic review and network meta-analysis. Platelets 30:8, pages 946-956.
Read now
Read now
Fazal-i-Akbar Danish & Saeeda Yasmin. (2013) The role of eltrombopag in the management of hepatitis C virus-related thrombocytopenia. Hepatic Medicine: Evidence and Research 5, pages 17-30.
Read now
Read now
Articles from other publishers (58)
Yunfei Chen, Jiaying Liu, Shuai Shao, Zhen Song, Yueshen Ma, Yuanyuan Tuo, Lijun Fang, Yanmei Xu, Bingqi Xu, Wenjing Gu, Xuan Cao, Jia Chen, Yu Yang, Panjing Wang, Jing Zhang, Yuan Xu, Dandan Yu, Pengxiao Hou, Ke Meng, Zhirong Li, Guanyu Liu, Xinmiao Qu, Lulu Ji, Renchi Yang & Lei Zhang. (2023)
Characteristics and outcomes of
COVID
‐19 in Chinese immune thrombocytopenia patients: A prospective cohort study
. British Journal of Haematology.
Crossref
Crossref
Catherine M Broome, Vickie McDonald, Yoshitaka Miyakawa, Monica Carpenedo, David J Kuter, Hanny Al-Samkari, James B Bussel, Marie Godar, Jaume Ayguasanosa, Kristof De Beuf, Francesco Rodeghiero, Marc Michel, Adrian Newland, Michael Fillitz, Paul Knoebl, Stef Meers, Ismail Mohamad Amine, Jaromir Gumulec, Antonin Hlusi, Jiri Mayer, Philippe Quittet, Jean-Francois Viallard, Magdana Betaneli, Irine Datikashvili-David, Genadi Iosava, Levan Makhaldiani, Laszlo Rejto, Nino Sharashenidze, Stefanie Groepper, Alexander Röth, Aryan Hamed, Arpad Illes, Monica Carpenedo, Andrea Artoni, Monica Bocchia, Barbara Gamberi, Alessandra Borchiellini, Esther Natalie Oliva, Andrea Patriarca, Simona Tomassetti, Yoshitaka Miyakawa, Kiyoshi Ando, Hiroshi Handa, Shinya Katsutani, Kaichi Nishiwaki, Shoko Ito, Tomoki Ito, Fransien de Boer, A.J. Gerard Jansen, Hanna Ciepluch, Szymon Fornagiel, Sebastian Grosicki, Maria Soroka-Wojtaszko, Jacek Trelinski, Bulat Bakirov, Elena Borisenkova, Elena Volodicheva, Yuri Shatokhin, Andrey Proydakov, Maria Aranzazu Alonso, María Eva Mingot-Castellano, Blanca Sanchez-Gonzalez, David Valcarcel Ferreiras, Meltem Ayli, Tuba Hacibekiroglu, Ahmet Muzaffer Demir, Meliha Nalçaci, Mehmet Sonmez, Anil Tombak, Selami Kocak Toprak, Burhan Turgut, Filiz Vural, Munci Yagci, Fevzi Altuntas, Mehmet Turgut, Emin Kaya, Nataliya Romanyuk, Vickie McDonald, Syed Rashid Saeed Kazmi, Catherine Broome, Spero Cataland, Ketan Doshi, Steven R. Lentz, Michael Boxer & Richard Rosenberg. (2023) Efficacy and safety of the neonatal Fc receptor inhibitor efgartigimod in adults with primary immune thrombocytopenia (ADVANCE IV): a multicentre, randomised, placebo-controlled, phase 3 trial. The Lancet 402:10413, pages 1648-1659.
Crossref
Crossref
Sandra Jonmarker, Jacob Litorell, Felix Alarcon, Kais Al-Abani, Sofia Björkman, Maria Farm, Jonathan Grip, Mårten Söderberg, Jacob Hollenberg, Rebecka Rubenson Wahlin, Thomas Kander, Liivi Rimling, Johan Mårtensson, Eva Joelsson-Alm, Martin Dahlberg & Maria Cronhjort. (2023) A retrospective multicenter cohort study of the association between anti-Factor Xa values and death, thromboembolism, and bleeding in patients with critical COVID-19. Thrombosis Journal 21:1.
Crossref
Crossref
Lijun Fang, Jing Sun, Yongqiang Zhao, Ming Hou, Depei Wu, Yunfei Chen, Renchi Yang & Lei Zhang. (2023) Efficacy and Safety Analysis of Combination Therapy Consisting of Intravenous Immunoglobulin and Corticosteroids versus Respective Monotherapies in the Treatment of Relapsed ITP in Adults. Global Medical Genetics 10:02, pages 087-096.
Crossref
Crossref
Yingying Li & Heng Mei. (2022) Whole-process management of complications during CAR-T therapy. Hematology and Oncology Discovery 1:1.
Crossref
Crossref
Sarah Tehseen, Suzan Williams, Joan Robinson, Shaun K. Morris, Ari Bitnun, Peter Gill, Tala El Tal, Ann Yeh, Carmen Yea, Rolando Ulloa‐Gutierrez, Helena Brenes‐Chacon, Adriana Yock‐Corrales, Gabriela Ivankovich‐Escoto, Alejandra Soriano‐Fallas, Jesse Papenburg, Marie‐Astrid Lefebvre, Rosie Scuccimarri, Alireza Nateghian, Behzad Haghighi Aski, Rachel Dwilow, Jared Bullard, Suzette Cooke, Lea Restivo, Alison Lopez, Manish Sadarangani, Ashley Roberts, Michelle Forbes, Nicole Le Saux, Jennifer Bowes, Rupeena Purewal, Janell Lautermilch, Ann Bayliss, Jacqueline K. Wong, Kirk Leifso, Cheryl Foo, Luc Panetta, Fatima Kakkar, Dominique Piche, Isabelle Viel‐Theriault, Joanna Merckx & Lani Lieberman. (2022) Thrombosis and hemorrhage experienced by hospitalized children with SARS‐CoV‐2 infection or MIS‐C: Results of the PICNIC registry. Pediatric Blood & Cancer 69:9.
Crossref
Crossref
Mickaël Roussotte, Mathieu Gerfaud-Valentin, Arnaud Hot, Sylvain Audia, Bernard Bonnotte, Thomas Thibault, Hervé Lobbes, Guillaume Le Guenno, Radjiv Goulabchand, Pascal Cathebras, Loig Varron, Jean François Dufour, Alban Deroux, Caroline Compain, Antoine Baudet, Ludovic Karkowski, Laurent Pérard, Mikael Ebbo, Jean-Christophe Lega & Pascal Sève. (2022) Immune thrombocytopenia with clinical significance in systemic lupus erythematosus: a retrospective cohort study of 90 patients. Rheumatology 61:9, pages 3627-3639.
Crossref
Crossref
Philippa Woolley, Anish Tailor, Raakhee Shah, John‐Paul Westwood & Marie Scully. (2022) Real‐world, single‐center experience of SARS‐CoV‐2 vaccination in immune thrombocytopenia. Journal of Thrombosis and Haemostasis 20:6, pages 1476-1484.
Crossref
Crossref
Sandra Jonmarker, Jacob Litorell, Martin Dahlberg, Otto Stackelberg, Åsa H. Everhov, Mårten Söderberg, Rebecka Rubenson‐Wahlin, Mattias Günther, Johan Mårtensson, Jacob Hollenberg, Eva Joelsson‐Alm & Maria Cronhjort. (2021) An observational study of intermediate‐ or high‐dose thromboprophylaxis for critically ill COVID‐19 patients. Acta Anaesthesiologica Scandinavica 66:3, pages 365-374.
Crossref
Crossref
Ye-Jun WuHui LiuQiao-Zhu ZengYi LiuJing-Wen WangWen-Sheng Wang Jia-Feng, He-Bing Zhou, Qiu-Sha HuangYun HeHai-Xia FuXiao-Lu ZhuQian JiangHao JiangYing-Jun ChangLan-Ping XuXiao-Jun Huang & Xiao-Hui Zhang. (2022)
All-
trans
retinoic acid plus low-dose rituximab vs low-dose rituximab in corticosteroid-resistant or relapsed ITP
. Blood 139:3, pages 333-342.
Crossref
Crossref
Ekaterina Baryshnikova. 2022. The Coagulation Labyrinth of Covid-19. The Coagulation Labyrinth of Covid-19
31
45
.
Sirui Zhang, Yupei Li, Guina Liu & Baihai Su. (2021) Intermediate-to-therapeutic versus prophylactic anticoagulation for coagulopathy in hospitalized COVID-19 patients: a systemic review and meta-analysis. Thrombosis Journal 19:1.
Crossref
Crossref
Qiu-Sha Huang, Yi Liu, Jing-Bo Wang, Jun Peng, Ming Hou, Hui Liu, Ru Feng, Jing-Wen Wang, Lan-Ping Xu, Yang Wang, Xiao-Jun Huang & Xiao-Hui Zhang. (2021) All-trans retinoic acid plus high-dose dexamethasone as first-line treatment for patients with newly diagnosed immune thrombocytopenia: a multicentre, open-label, randomised, controlled, phase 2 trial. The Lancet Haematology 8:10, pages e688-e699.
Crossref
Crossref
Kristin A Shimano, Rachael F Grace, Jenny M Despotovic, Ellis J Neufeld, Robert J Klaassen, Carolyn M Bennett, Clement Ma, Wendy B London & Cindy Neunert. (2021) Phase 3 randomised trial of eltrombopag versus standard first-line pharmacological management for newly diagnosed immune thrombocytopaenia (ITP) in children: study protocol. BMJ Open 11:8, pages e044885.
Crossref
Crossref
Emily Sirotich, Gordon Guyatt, Caroline Gabe, Zhikang Ye, Carolyn E Beck, Vicky Breakey, Nichola Cooper, Adam Cuker, Jay Charness, Kerstin de Wit, Jennifer DiRaimo, Steven G. Fein, Rachael F. Grace, Ziauddin Hassan, Erin Jamula, Matthew Kang, Charles F. Manski, Clare O'Connor, Menaka Pai, Dale Paynter, Stephen C. Porter, Barbara Pruitt, Gail Strachan, Kathryn E. Webert, Justin W. Yan, John G. Kelton, Tamam Bakchoul & Donald M. Arnold. (2021) Definition of a critical bleed in patients with immune thrombocytopenia: Communication from the ISTH SSC Subcommittee on Platelet Immunology. Journal of Thrombosis and Haemostasis 19:8, pages 2082-2088.
Crossref
Crossref
John E. Stillson, Connor M. Bunch, Laura Gillespie, Rashid Khan, Meredith Wierman, Joseph Pulvirenti, Htay Phyu, Stephen Anderson, Mahmoud Al-Fadhl, Anthony V. Thomas, Hau C. Kwaan, Ernest Moore, Hunter Moore & Mark M. Walsh. (2021) Thromboelastography-Guided Management of Anticoagulated COVID-19 Patients to Prevent Hemorrhage. Seminars in Thrombosis and Hemostasis 47:04, pages 442-446.
Crossref
Crossref
Hongli Zhao, Jiayue Sun, Liru Yan, Bo Jin, Wenyi Hou, Fenglin Cao, Haitao Li, Jin Zhou & Yingmei Zhang. (2021) Tissue factor–bearing microparticles are a link between acute promyelocytic leukemia cells and coagulation activation: a human subject study. Annals of Hematology 100:6, pages 1473-1483.
Crossref
Crossref
Qiu‐Sha Huang, Xiao‐Lu Zhu, Qing‐Yuan Qu, Xiao Liu, Gao‐Chao Zhang, Yan Su, Qi Chen, Feng‐Qi Liu, Xue‐Yan Sun, Mei‐Ying Liang, Yi Liu, Ming Jiang, Hui Liu, Ru Feng, Hong‐Xia Yao, Lei Zhang, Shen‐Xian Qian, Tong‐Hua Yang, Jing‐Yu Zhang, Xu‐Liang Shen, Lin‐Hua Yang, Jian‐Da Hu, Ren‐Wei Huang, Zhong‐Xing Jiang, Jing‐Wen Wang, Hong‐Yu Zhang, Zhen Xiao, Si‐Yan Zhan, Hui‐Xin Liu, Ying‐Jun Chang, Qian Jiang, Hao Jiang, Jin Lu, Lan‐Ping Xu, Xiao‐Hong Zhang, Cheng‐Hong Yin, Jian‐Liu Wang, Xiao‐Jun Huang & Xiao‐Hui Zhang. (2021)
Prediction of postpartum hemorrhage in pregnant women with immune thrombocytopenia: Development and validation of the
MONITOR
model in a nationwide multicenter study
. American Journal of Hematology 96:5, pages 561-570.
Crossref
Crossref
Savvas Kolanis, Eleni Vasileiou, Emmanuel Hatzipantelis, Marina Economou & Athanasios Tragiannidis. (2021) Safety and Efficacy of Eltrombopag in Children and Adults with Immune Thrombocytopenia: A Systematic Review and Meta-Analysis. Cardiovascular & Hematological Agents in Medicinal Chemistry 19:1, pages 83-92.
Crossref
Crossref
Corinne M. Eschler, Ana Antelo, Georg-Christian Funk, Aristomenis K. Exadaktylos & Gregor Lindner. (2021) High Fluctuation Between Anticoagulants, Frequent Off-Label Dosing, and No Difference Concerning Outcomes: Results of a Real-Life Cohort Study. The American Journal of Medicine 134:3, pages e165-e170.
Crossref
Crossref
S Akin & IC Haznedaroglu. (2021) Clinical variations between three different causes of thrombocytopenia. Nigerian Journal of Clinical Practice 24:1, pages 17.
Crossref
Crossref
Sandra Jonmarker, Jacob Hollenberg, Martin Dahlberg, Otto Stackelberg, Jacob Litorell, Åsa H. Everhov, Hans Järnbert-Pettersson, Mårten Söderberg, Jonathan Grip, Anna Schandl, Mattias Günther & Maria Cronhjort. (2020) Dosing of thromboprophylaxis and mortality in critically ill COVID-19 patients. Critical Care 24:1.
Crossref
Crossref
Kimmo Weisshaar, Hannah Ewald, Jörg Halter, Sabine Gerull, Sandra Schönfeld, Yuliya Senft, Maria Martinez, Anne Leuppi-Taegtmeyer, Nina Khanna, Birgit Maier, Antonio Risitano, Regis Peffault de Latour, Andre Tichelli, Jakob Passweg & Beatrice Drexler. (2020) Development of a patient-reported outcome questionnaire for aplastic anemia and paroxysmal nocturnal hemoglobinuria (PRO-AA/PNH). Orphanet Journal of Rare Diseases 15:1.
Crossref
Crossref
Mingjing Wang, Weiyi Liu, Yonggang Xu, Hongzhi Wang, Xiaoqing Guo, Xiaoqing Ding, Richeng Quan, Haiyan Chen, Shirong Zhu, Teng Fan, Yujin Li, Xuebin Zhang, Yan Sun & Xiaomei Hu. (2020) Predicting bleeding risk in a Chinese immune thrombocytopenia (ITP) population: development and assessment of a new predictive nomogram. Scientific Reports 10:1.
Crossref
Crossref
Philippa Woolley, Rosalind Newton, Siobhan Mc Guckin, Mari Thomas, John‐Paul Westwood & Marie A. Scully. (2020) Immune thrombocytopenia in adults: A single‐centre review of demographics, clinical features and treatment outcomes. European Journal of Haematology 105:3, pages 344-351.
Crossref
Crossref
Ying Wang, Kunming Qi, Hai Cheng, Jiang Cao, Ming Shi, Jianlin Qiao, Zhiling Yan, Guangjun Jing, Bin Pan, Wei Sang, Depeng Li, Xiangmin Wang, Chunling Fu, Feng Zhu, Junnian Zheng, Zhenyu Li & Kailin Xu. (2020) Coagulation Disorders after Chimeric Antigen Receptor T Cell Therapy: Analysis of 100 Patients with Relapsed and Refractory Hematologic Malignancies. Biology of Blood and Marrow Transplantation 26:5, pages 865-875.
Crossref
Crossref
Corinne M. Eschler, Bertram K. Woitok, Georg-Christian Funk, Philipp Walter, Volker Maier, Aristomenis K. Exadaktylos & Gregor Lindner. (2020) Oral Anticoagulation in Patients in the Emergency Department: High Rates of Off-Label Doses, No Difference in Bleeding Rates. The American Journal of Medicine 133:5, pages 599-604.
Crossref
Crossref
Michio Ozeki, Akifumi Nozawa, Shiho Yasue, Saori Endo, Ryuta Asada, Hiroya Hashimoto & Toshiyuki Fukao. (2019) The impact of sirolimus therapy on lesion size, clinical symptoms, and quality of life of patients with lymphatic anomalies. Orphanet Journal of Rare Diseases 14:1.
Crossref
Crossref
Hai Zhou, Ping Qin, Qiang Liu, Chenglu Yuan, Yunliang Hao, Haiyan Zhang, Zhencheng Wang, Xuehong Ran, Xiaoxia Chu, Wenzheng Yu, Xin Wang, Yu Hou, Jun Peng & Ming Hou. (2019) A prospective, multicenter study of low dose decitabine in adult patients with refractory immune thrombocytopenia. American Journal of Hematology 94:12, pages 1374-1381.
Crossref
Crossref
Charlotta Ekstrand, Marie Linder, Honar Cherif, Helle Kieler & Shahram Bahmanyar. (2019) Patient characteristics when starting treatment and patterns of treatment in adults with chronic immune thrombocytopenia. Blood Coagulation & Fibrinolysis 30:7, pages 350-356.
Crossref
Crossref
E Nuttall Musson, O Lomas & MF Murphy. (2019) Acute thrombocytopenia: picking a way through a paucity of platelets. British Journal of Hospital Medicine 80:9, pages 507-512.
Crossref
Crossref
Munira Borhany, Alexandre Ranc, Mathilde Fretigny, Grégory Moulis, Madiha Abid, Tahir Shamsi & Muriel Giansily‐Blaizot. (2019) Molecular analysis of eight severe FV‐deficient patients in Pakistan: A large series of homozygous for frameshift mutations. Haemophilia 25:4.
Crossref
Crossref
Michio Ozeki, Ryuta Asada, Akiko M. Saito, Hiroya Hashimoto, Takumi Fujimura, Tatsuo Kuroda, Shigeru Ueno, Shoji Watanabe, Shunsuke Nosaka, Mikiko Miyasaka, Akihiro Umezawa, Kentaro Matsuoka, Takanobu Maekawa, Yohei Yamada, Akihiro Fujino, Satoshi Hirakawa, Taizo Furukawa, Tatsuro Tajiri, Yoshiaki Kinoshita, Ryota Souzaki & Toshiyuki Fukao. (2019) Efficacy and safety of sirolimus treatment for intractable lymphatic anomalies: A study protocol for an open-label, single-arm, multicenter, prospective study (SILA). Regenerative Therapy 10, pages 84-91.
Crossref
Crossref
Sarah H. O'Brien, Jenny M. Despotovic & Cindy E. Neunert. (2019) Intravenous Immunoglobulin Versus Anti-D Immunoglobulin: When Better Treatment May Not Be the Best Treatment. The Journal of Pediatrics 204, pages 11-13.
Crossref
Crossref
Bertrand Lioger, François Maillot, David Ternant, Christophe Passot, Gilles Paintaud & Theodora Bejan-Angoulvant. (2019) Efficacy and Safety of Anti-D Immunoglobulins versus Intravenous Immunoglobulins for Immune Thrombocytopenia in Children: Systematic Review and Meta-analysis of Randomized Controlled Trials. The Journal of Pediatrics 204, pages 225-233.e8.
Crossref
Crossref
Mostafa Ebraheem Morra, Ahmed M.A. Altibi, Somia Iqtadar, Le Huu Nhat Minh, Sameh Samir Elawady, Asma Hallab, Abdelrahman Elshafay, Omer Abedlbagi Omer, Ahmed Iraqi, Purushottam Adhikari, Jonair Hussein Labib, Khaled Mosaad Elhusseiny, Ahmed Elgebaly, Sophie Yacoub, Le Thi Minh Huong, Kenji Hirayama & Nguyen Tien Huy. (2018) Definitions for warning signs and signs of severe dengue according to the WHO 2009 classification: Systematic review of literature. Reviews in Medical Virology 28:4, pages e1979.
Crossref
Crossref
Yilun Tang, Yan Xu, Zhibin Shi, Xiaorong Ma, Lihong Fan, Kunzheng Wang & Xiaoqian Dang. (2018) Multiple total hip arthroplasties in refractory immune thrombocytopenic purpura. Medicine 97:15, pages e0308.
Crossref
Crossref
Raymond S. M. WongMansoor N. SalehAbderrahim KhelifAbdulgabar SalamaMaria Socorro O. PortellaPaul Burgess & James B. Bussel. (2017) Safety and efficacy of long-term treatment of chronic/persistent ITP with eltrombopag: final results of the EXTEND study. Blood 130:23, pages 2527-2536.
Crossref
Crossref
Lukas Löfling, Marie Linder, Charlotta Ekstrand, Honar Cherif, Helle Kieler & Shahram Bahmanyar. (2017) Pharmacological agents preceding a diagnosis of immune thrombocytopenia in adult patients developing the chronic form: A Swedish national register study. Thrombosis Research 160, pages 27-31.
Crossref
Crossref
Rahajeng N. Tunjungputri, Muhammad Hussein Gasem, Willemijn van der Does, Pandu H. Sasongko, Bambang Isbandrio, Rolf T. Urbanus, Philip G. de Groot, Andre van der Ven & Quirijn de Mast. (2017) Platelet dysfunction contributes to bleeding complications in patients with probable leptospirosis. PLOS Neglected Tropical Diseases 11:9, pages e0005915.
Crossref
Crossref
Irina Ivanovna Zotova, S.V. Gritsaev, E.R. Shilova, N.A. Potikhonova, K.M. Abdulkadyrov & A.V. Chechetkin. (2017) Thrombopoietin Receptor Agonists in Treatment of Idiopathic Thrompocytopenic Purpura (Primary Immune Thrombocytopenia): Efficacy and Safety in Everyday Clinical Practice. Clinical oncohematology 10:1, pages 93-100.
Crossref
Crossref
Renchi Yang, Junmin Li, Jie Jin, Meijuan Huang, Ziqiang Yu, Xiaojun Xu, Xiaohui Zhang & Ming Hou. (2017) Multicentre, randomised phase III study of the efficacy and safety of eltrombopag in Chinese patients with chronic immune thrombocytopenia. British Journal of Haematology 176:1, pages 101-110.
Crossref
Crossref
Jesper Stentoft. (2016) ITP: from idiopathic purpura to immune thrombocytopenia and back. British Journal of Haematology 175:5, pages 755-756.
Crossref
Crossref
María T. Álvarez-Román, Ihosvany Fernández-Bello, Víctor Jiménez-Yuste, Mónica Martín-Salces, Elena G. Arias-Salgado, María I. Rivas Pollmar, Raúl Justo Sanz & Nora V. Butta. (2016) Procoagulant profile in patients with immune thrombocytopenia. British Journal of Haematology 175:5, pages 925-934.
Crossref
Crossref
Carol Hindley. (2016) Immune thrombocytopaenia in pregnancy: Key principles for the midwife. British Journal of Midwifery 24:11, pages 768-772.
Crossref
Crossref
A. Eghbali, L. Melikof, H. Taherahmadi & B. Bagheri. (2016) Efficacy of tranexamic acid for the prevention of bleeding in patients with von Willebrand disease and Glanzmann thrombasthenia: a controlled, before and after trial. Haemophilia 22:5, pages e423-e426.
Crossref
Crossref
Harmanpreet Kaur, Munira Borhany, Hanan Azzam, Carolina Costa-Lima, Margareth Ozelo & Maha Othman. (2016) The utility of International Society on Thrombosis and Haemostasis-Bleeding Assessment Tool and other bleeding questionnaires in assessing the bleeding phenotype in two platelet function defects. Blood Coagulation & Fibrinolysis 27:5, pages 589-593.
Crossref
Crossref
C. Ekstrand, M. Linder, H. Cherif, H. Kieler & S. Bahmanyar. (2016) Increased susceptibility to infections before the diagnosis of immune thrombocytopenia. Journal of Thrombosis and Haemostasis 14:4, pages 807-814.
Crossref
Crossref
C. Neunert, N. Noroozi, G. Norman, G.R. Buchanan, J. Goy, I. Nazi, J.G. Kelton & D.M. Arnold. (2015) Severe bleeding events in adults and children with primary immune thrombocytopenia: a systematic review. Journal of Thrombosis and Haemostasis 13:3, pages 457-464.
Crossref
Crossref
Helen E. Campbell, Lise J. Estcourt, Elizabeth A. Stokes, Charlotte A. Llewelyn, Michael F. Murphy, Erica M. Wood & Simon J. Stanworth. (2014) Prophylactic platelet transfusions in patients with blood malignancies: cost analysis of a randomized trial. Transfusion 54:10, pages 2394-2403.
Crossref
Crossref
Kavitha Ramaswamy, Loan Hsieh, Emily Leven, Michaela V. Thompson, Diane Nugent & James B. Bussel. (2014) Thrombopoietic Agents for the Treatment of Persistent and Chronic Immune Thrombocytopenia in Children. The Journal of Pediatrics 165:3, pages 600-605.e4.
Crossref
Crossref
Lise J. Estcourt, Deborah Pinchon, Emily Symington, Anne M. Kelly, Carolyn Doree, Susan Brunskill, Liz Glidewell & Simon Stanworth. (2014) Does bleeding affect patient-reported outcome measures in patients with myelodysplasia or hematologic malignancies: a systematic review. Transfusion 54:4, pages 1166-1179.
Crossref
Crossref
Abdulgabar SalamaAxel Matzdorff. 2013. Current & Emerging Treatments for Immune Thrombocytopenia. Current & Emerging Treatments for Immune Thrombocytopenia
30
45
.
Mansoor N. SalehJames B. BusselGregory ChengOliver Meyer, Christine K. Bailey, Michael Arning & Andres Brainsky. (2013) Safety and efficacy of eltrombopag for treatment of chronic immune thrombocytopenia: results of the long-term, open-label EXTEND study. Blood 121:3, pages 537-545.
Crossref
Crossref
Rachael F. Grace. (2013) Standardized Clinical Assessment and Management Plans (SCAMPs): Perspectives on a New Method to Understand Treatment Decisions and Outcomes in Immune Thrombocytopenia. Seminars in Hematology 50, pages S31-S38.
Crossref
Crossref
Hans Gombotz & Gerhard Lanzer. 2013. Evidence-Based Practice of Anesthesiology. Evidence-Based Practice of Anesthesiology
164
173
.
S. LAKSHMANAN & A. CUKER. (2012) Contemporary management of primary immune thrombocytopenia in adults. Journal of Thrombosis and Haemostasis 10:10, pages 1988-1998.
Crossref
Crossref
Paula James & Barry S. Coller. (2012) Phenotyping bleeding. Current Opinion in Hematology 19:5, pages 406-412.
Crossref
Crossref